MichaelA.SafdiMD

Physician

Dr. Safdi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2925 Vernon Pl
Suite 100
Cincinnati, OH 45219
Phone+1 513-751-6667

Fax+1 513-872-4553

Scripps Clinic/Scripps Green HospitalFellowship, Gastroenterology, 1979 - 1980
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 1978 - 1979
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1975 - 1977
University of Cincinnati College of MedicineClass of 1975

PubMed

400 citations
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
Paul Rutgeerts, Robert H. Diamond, Mohan Bala, Allan Olson, Gary R. Lichtenstein
Gastrointestinal Endoscopy. 2006-03-01
228 citations
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
Stephen B. Hanauer, J Schwartz, Malcolm Robinson, W Roufail, Sanjeev Arora
The American Journal of Gastroenterology. 1993-08-01
83 citations
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: A randomized, double-blind, placebo-controlled, dose-escalation trial
William J. Sandborn, Bruce E. Sands, Douglas C. Wolf, John F. Valentine, Michael Safdi
Alimentary Pharmacology & Therapeutics. 2003-06-01

Journal Articles

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report
Russell D Cohen, Uma Mahadevan, Bruce A Salzberg, Gary R Lichtenstein, William J Sandborn, Michael Safdi, Nature